MonTa Biosciences ApS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours (NCT04855435) | MonTa Biosciences ApS | 2021-04-12 |
Track MonTa Biosciences ApS automatically
Every clearance here is in the API, with alerts when new ones post.